Elizabeth Almonte

Elizabeth Almonte currently serves as the Senior Manager of Regulatory Operations at CRISPR Therapeutics, a position held since December 2019. Prior to this role, Elizabeth accumulated extensive experience at Boehringer Ingelheim from 2008 to December 2019, holding various positions including Specialist in Product Maintenance and Compliance and Specialist in Global Submission Services. Additionally, Elizabeth worked as a Regulatory Affairs Associate IV at Watson Pharma Pvt Ltd from 2006 to 2008 and began a career at Boehringer Ingelheim as a Study Director Assistant from 2004 to 2006. Elizabeth holds a Master’s degree in Medical Health Science from Quinnipiac University, attended from 2004 to 2006.